Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis

被引:49
|
作者
Pierrot-Deseilligny, Charles [1 ]
Souberbielle, Jean-Claude [2 ]
机构
[1] Univ Paris 06, Hop La Pitie Salpetriere, AP HP, Serv Neurol 1, Paris, France
[2] Univ Paris 05, Hop Necker Enfants Malad, AP HP, Serv Explorat Fonct, Paris, France
关键词
Epstein-Barr virus; genetics; multiple sclerosis; smoking; vitamin D; EPSTEIN-BARR-VIRUS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; SERUM 25-HYDROXYVITAMIN D; BONE-MINERAL DENSITY; ENVIRONMENTAL RISK-FACTORS; CENTRAL-NERVOUS-SYSTEM; PLACEBO-CONTROLLED TRIAL; REGULATORY T-CELLS; D-RECEPTOR GENE; 1,25-DIHYDROXYVITAMIN D-3;
D O I
10.1177/1756285612473513
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis (MS) is reviewed. Among the multiple recently discovered actions of vitamin D, an immunomodulatory role has been documented in experimental autoimmune encephalomyelitis and in humans. This action in the peripheral immune system is currently the main known mechanism through which vitamin D might influence MS, but other types of actions could be involved within the central nervous system. Furthermore, vitamin D insufficiency is widespread in temperate countries and in patients with MS at the earliest stages of the disease, suggesting that the deleterious effects related to vitamin D insufficiency may be exerted in these patients. In fact, many genetic and environmental risk factors appear to interact and contribute to MS. In genetics, several human leukocyte antigen (HLA) alleles (more particularly HLA-DRB1*1501) could favour the disease whereas some others could be protective. Some of the genes involved in vitamin D metabolism (e.g. CYP27B1) also play a significant role. Furthermore, three environmental risk factors have been identified: past Epstein-Barr virus infection, vitamin D insufficiency and cigarette smoking. Interactions between genetic and environmental risk or protective factors may occur during the mother's pregnancy and could continue during childhood and adolescence and until the disease is triggered in adulthood, therefore possibly modulating the MS risk throughout the first decades of life. Furthermore, some clinical findings already strongly suggest that vitamin D status influences the relapse rate and radiological lesions in patients with MS, although the results of adequately powered randomized clinical trials using vitamin D supplementation have not yet been reported. While awaiting these incontrovertible results, which might be long in coming, patients with MS who are currently in vitamin D insufficiency should be supplemented, at least for their general health status, using moderate doses of the vitamin.
引用
收藏
页码:81 / 116
页数:36
相关论文
共 50 条
  • [21] Multiple Sclerosis: New Insights in Pathogenesis and Novel Therapeutics
    Ontaneda, Daniel
    Hyland, Megan
    Cohen, Jeffrey A.
    ANNUAL REVIEW OF MEDICINE, VOL 63, 2012, 63 : 389 - 404
  • [22] Multiple Sclerosis Pathogenesis: Possible Interplay between Vitamin D Status and Epstein Barr Virus Infection
    Bivona, Giulia
    Scazzone, Concetta
    Lo Sasso, Bruna
    Giglio, Rosaria Vincenza
    Gambino, Caterina Maria
    Agnello, Luisa
    Ciaccio, Marcello
    JOURNAL OF INTEGRATIVE NEUROSCIENCE, 2023, 22 (01) : 7
  • [23] Polymorphisms in vitamin D metabolism related genes and risk of multiple sclerosis
    Simon, K. Claire
    Munger, Kassandra L.
    Yang, Xing
    Ascherio, Alberto
    MULTIPLE SCLEROSIS JOURNAL, 2010, 16 (02) : 133 - 138
  • [24] Metabolomics: A potential way to know the role of vitamin D on multiple sclerosis
    Luque-Cordoba, Diego
    Luque de Castro, Maria D.
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2017, 136 : 22 - 31
  • [25] Multiple Sclerosis: Updates on Pathogenesis and Therapy
    Hohlfeld, R.
    Toyka, K. V.
    NERVENARZT, 2011, 82 (08): : 1026 - +
  • [26] Is hypovitaminosis D one of the environmental risk factors for multiple sclerosis?
    Pierrot-Deseilligny, Charles
    Souberbielle, Jean-Claude
    BRAIN, 2010, 133 : 1869 - 1888
  • [27] Vitamin D treatment in multiple sclerosis
    Myhr, Kjell-Morten
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 286 (1-2) : 104 - 108
  • [28] The role of vitamin D in multiple sclerosis
    Kampman, Margitta T.
    Steffensen, Linn H.
    JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY, 2010, 101 (02) : 137 - 141
  • [29] Full spectrum of vitamin D immunomodulation in multiple sclerosis: mechanisms and therapeutic implications
    Galoppin, Manon
    Kari, Saniya
    Soldati, Sasha
    Pal, Arindam
    Rival, Manon
    Engelhardt, Britta
    Astier, Anne
    Thouvenot, Eric
    BRAIN COMMUNICATIONS, 2022, 4 (04)
  • [30] Vitamin D and other environmental risk factors in Colombian patients with multiple sclerosis
    Toro, Jaime
    Reyes, Saul
    Diaz-Cruz, Camilo
    Burbano, Lisseth
    Cuellar-Giraldo, David Felipe
    Duque, Alejandra
    Reyes-Mantilla, Maria I.
    Torres, Camilo
    Rios, Jorge
    Rivera, Juan Sebastian
    Cortes-Munoz, Fabian
    Patino, Jorge
    Noriega, Daniel
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 41